NRx Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $25.8M
Liabilities Breakdown FY2022
Total Liabilities: $18.4M
Asset Breakdown
Total Assets: $25.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $20.1M | 77.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $5.8M | 22.3% |
Liabilities Breakdown
Total Liabilities: $18.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 11.3% |
| Long-Term Debt | $2.8M | 15.3% |
| Other Liabilities | $13.5M | 73.4% |